Promising Indicators in Probiotic-recommendations in COVID-19 and its Accompanying Diseases

Vardan V. Tsaturyan, Almagul R. Kushugulova, Susanna Mirzabekyan, Ketevan Sidamonidze, David Tsereteli, Tamas Torok, Astghik Pepoyan

2022

Full text Open access: Gold Metadata (CSL-JSON)

DOI 10.3889/oamjms.2022.7989

Data confidence 70 medium

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Scientific data suggests the possible beneficial role of probiotics in treatments for COVID-19, but the species/strains-specificity and disease-specificity of probiotics need high attention in choosing the appropriate probiotic in diseases, in particularly in the COVID-19. We hope this review will raise awareness of the COVID-19 probiotic recommendations, highlighting the latest scientific information about virus/hydrogen peroxide/probiotics and the importance of finding out of a specific “criterion” for the probiotics’ recommendation in this disease.